NasdaqCM:CHFS

Stock Analysis Report

Executive Summary

CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload.

Snowflake

Fundamentals

Mediocre balance sheet with limited growth.

Risks

  • CHF Solutions has significant price volatility in the past 3 months.
  • CHF Solutions is covered by less than 3 analysts.

Similar Companies

Share Price & News

How has CHF Solutions's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

4.1%

NasdaqCM:CHFS

-1.6%

US Medical Equipment

-1.6%

US Market


1 Year Return

-84.5%

NasdaqCM:CHFS

10.2%

US Medical Equipment

-3.0%

US Market

CHFS underperformed the Medical Equipment industry which returned 13.6% over the past year.

CHFS underperformed the Market in United States of America which returned -0% over the past year.


Share holder returns

CHFSIndustryMarket
7 Day4.1%-1.6%-1.6%
30 Day-9.6%-3.5%-5.8%
90 Day-24.6%7.4%0.2%
1 Year-84.5%-84.5%11.1%10.2%-0.8%-3.0%
3 Year-100.0%-100.0%65.1%60.0%38.0%29.1%
5 Year-100.0%-100.0%127.0%101.0%50.8%34.1%

Price Volatility Vs. Market

How volatile is CHF Solutions's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is CHF Solutions undervalued based on future cash flows and its price relative to the stock market?

0.7x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for CHF Solutions to establish if it is available at moderate discount.

Unable to calculate intrinsic value for CHF Solutions to establish if it is available at substantial discount.


Price Based on Earnings

CHF Solutions is loss making, we can't compare its value to the US Medical Equipment industry average.

CHF Solutions is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for CHF Solutions, we can't assess if its growth is good value.


Price Based on Value of Assets

CHF Solutions is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is CHF Solutions expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

44.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

CHF Solutions's revenue is expected to grow significantly at over 20% yearly.

CHF Solutions is not considered high growth as it is expected to be loss making for the next 1-3 years.

CHF Solutions's revenue growth is expected to exceed the United States of America market average.

Unable to compare CHF Solutions's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.

Unable to compare CHF Solutions's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if CHF Solutions will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has CHF Solutions performed over the past 5 years?

4.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

CHF Solutions does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare CHF Solutions's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare CHF Solutions's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if CHF Solutions has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if CHF Solutions has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if CHF Solutions improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is CHF Solutions's financial position?


Financial Position Analysis

CHF Solutions is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

CHF Solutions's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

CHF Solutions's level of debt (0%) compared to net worth is satisfactory (less than 40%).

Unable to establish if CHF Solutions's debt level has increased without past 5-year debt data.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 9.2792166722338E+16x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

CHF Solutions has less than a year of cash runway based on current free cash flow.

CHF Solutions has less than a year of cash runway if free cash flow continues to reduce at historical rates of -5.1% each year.


Next Steps

Dividend

What is CHF Solutions's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate CHF Solutions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate CHF Solutions's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as CHF Solutions has not reported any payouts.

Unable to verify if CHF Solutions's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as CHF Solutions has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of CHF Solutions's salary, the management and board of directors tenure and is there insider trading?

1.0yrs

Average management tenure


CEO

John Erb (70yo)

3.8yrs

Tenure

US$2,639,169

Compensation

Mr. John L. Erb has been the Chief Executive Officer and President of CHF Solutions, Inc. (also known as Sunshine Heart Inc.) since November 2015. Mr. Erb has been a Director of Electromed, Inc. since Augu ...


CEO Compensation Analysis

John's remuneration is higher than average for companies of similar size in United States of America.

John's compensation has increased whilst company is loss making.


Management Age and Tenure

1.0yrs

Average Tenure

51.5yo

Average Age

The average tenure for the CHF Solutions management team is less than 2 years, this suggests a new team.


Board Age and Tenure

6.4yrs

Average Tenure

66.5yo

Average Age

The tenure for the CHF Solutions board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyUS$49,99612 Mar 19
John Erb
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares9,523
Max PriceUS$5.25

Ownership Breakdown


Management Team

  • John Erb (70yo)

    Chairman

    • Tenure: 3.8yrs
    • Compensation: US$2.64m
  • Nestor Jaramillo (62yo)

    Chief Commercial Officer

    • Tenure: 0.3yrs
  • Carrie Powers (44yo)

    Senior Vice President of Commercial Operations

    • Tenure: 0.8yrs
  • David Lerner

    Sr. Vice President of Corporate Development & Technology

    • Tenure: 0.4yrs
  • Claudia Drayton (51yo)

    Chief Financial Officer

    • Tenure: 4.6yrs
    • Compensation: US$977.67k
  • Thomas Lynch (52yo)

    VP, General Counsel

    • Tenure: 1.0yrs
  • Sandra Eayrs

    Senior Vice President of Human Resources

    • Tenure: 4.6yrs
  • Laurent Duhoux

    Vice President of International Business Development

    • Tenure: 1.0yrs
  • Vitaliy Epshteyn (41yo)

    Sr. Vice President of Operations & Engineering

    • Tenure: 1.6yrs

Board Members

  • John Erb (70yo)

    Chairman

    • Tenure: 3.8yrs
    • Compensation: US$2.64m
  • Greg Waller (69yo)

    Director

    • Tenure: 8.0yrs
    • Compensation: US$246.04k
  • Warren Watson (67yo)

    Lead Independent Director

    • Tenure: 0.0yrs
    • Compensation: US$226.16k
  • Jon Salveson (54yo)

    Non Executive Director

    • Tenure: 6.4yrs
    • Compensation: US$226.16k
  • Matt Likens (66yo)

    Non-Executive Director

    • Tenure: 2.5yrs
    • Compensation: US$186.42k
  • Steve Brandt (63yo)

    Non-Executive Director

    • Tenure: 2.5yrs
    • Compensation: US$186.42k

Company Information

CHF Solutions, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CHF Solutions, Inc.
  • Ticker: CHFS
  • Exchange: NasdaqCM
  • Founded: 1999
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$6.565m
  • Shares outstanding: 2.58m
  • Website: https://www.chf-solutions.com

Number of Employees


Location

  • CHF Solutions, Inc.
  • 12988 Valley View Road
  • Eden Prairie
  • Minnesota
  • 55344
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CHFSNasdaqCM (Nasdaq Capital Market)YesOrdinary SharesUSUSDFeb 2012
22S3DB (Deutsche Boerse AG)YesOrdinary SharesDEEURFeb 2012

Biography

CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The company’s commercial product is the Aquadex FlexFlow system, which is in ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/24 00:48
End of Day Share Price2019/08/23 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.